Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Spring 2015 - Safety
Download Issue
Share
Up Front
Publisher's Corner
Safe Medicine: A Shared Responsibility
By Patrick M. Schmidt
Features
Foodborne Illness: A Continuing Threat to Public Health
By
Jim Trageser
Should There Be a ‘Right to Try’?
By
Kevin O’Hanlon
Myths and Facts: Obesity
By
Trudie Mitschang
Safety in Medicine: Ensuring the Integrity of Drugs
By
Ronale Tucker Rhodes, MS
Biosimilars: The Race for Approval
By
Amy Scanlin, MS
BioTrends Watch
Washington Report
Healthcare Providers' Medicare Appeals Further Delayed
Most Hospitals Will Fail to Collect on Medicare Quality Bonuses
HHS Announces $840 Million Transforming Clinical Practice Initiative to Improve Patient Care and Lower Costs
President’s FY2016 Budget Set to Reduce Net Medicare Spending
Reimbursement FAQs
Payments for Healthcare: A New Day Is Coming
Industry News
Limiting Spending for Some Medical Services Increases
ADMA Biologics' IVIG Product (RI-002) Receives Positive Phase III Results
Biosimilars 20/20 Conference Scheduled for June
New Needle-Free Vaccine Stimulates Immune Response
Second Octapharma Octagam 10% Manufacturing Site Approved by FDA
People and Places in the News
Severe PIs: Cutting-Edge Science Turns Tragedies to Cures
2014-15 Flu Vaccine Efficacy Low, But Still Recommended
BioFocus
Patient Profile
Sleep Disorders: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Sleep Disorders: A Physician's Perspective
By Trudie Mitschang
BioSources
BioResearch
Higher Dosages of 25% Albumin Associated with Lower Incidence of Cerebral Ischemia and Infarction in Pilot ALISAH Study
4-Factor Prothrombin Complex Concentrate Superior to 3-Factor Version for Reversal of Coumarin Anticoagulation in Rat Model
IVIG to SCIG Switch in CIDP & MMN Patients: Improved Tolerability and Patient Satisfaction